McClarren Financial Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16
Closed -$2K 322
2024
Q4
$2K Buy
+16
New +$3.11K 0.01% 180
2024
Q3
Sell
-133
Closed -$2K 292
2024
Q2
$2K Buy
+133
New +$25.2K ﹤0.01% 280
2024
Q1
Sell
-16
Closed -$3K 388
2023
Q4
$3K Hold
16
﹤0.01% 310
2023
Q3
$3K Hold
16
﹤0.01% 292
2023
Q2
$5K Hold
16
﹤0.01% 284
2023
Q1
$3K Hold
16
﹤0.01% 282
2022
Q4
$4K Hold
16
﹤0.01% 284
2022
Q3
$2K Buy
+16
New +$3.21K ﹤0.01% 277
2022
Q2
Sell
-16
Closed -$4K 138
2022
Q1
$4K Hold
16
﹤0.01% 239
2021
Q4
$4K Hold
16
﹤0.01% 272
2021
Q3
$3K Hold
16
﹤0.01% 249
2021
Q2
$3K Hold
16
﹤0.01% 262
2021
Q1
$3K Hold
16
﹤0.01% 230
2020
Q4
$3K Buy
+16
New +$2.62K ﹤0.01% 195

Other funds holding INSP

McClarren Financial Advisors's INSP Position: Q1 2025 in Review

McClarren Financial Advisors sold out of Inspire Medical Systems (INSP) in Q1 2025, closing a stake of 16 shares — an estimated $2K sold.

McClarren Financial Advisors first reported a position in INSP in Q4 2020 and held it in 14 quarters. The position peaked at $5K in Q2 2023. 363 funds tracked by Wall St. Rank hold INSP as of Q1 2025.

  • McClarren Financial Advisors reported no remaining Inspire Medical Systems position as of Q1 2025 after selling out during the quarter.
  • McClarren Financial Advisors sold 16 Inspire Medical Systems shares in Q1 2025, an estimated $2K.
  • McClarren Financial Advisors first reported a position in Inspire Medical Systems in Q4 2020 and held it in 14 quarters.
  • McClarren Financial Advisors's Inspire Medical Systems position peaked at $5K in Q2 2023.
  • 363 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2025.

Based on McClarren Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.